Longfellow Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.46M Hold
301,435
1.76% 12
2025
Q4
$7.51M Hold
301,435
1.69% 11
2025
Q3
$7.68M Hold
301,435
1.82% 9
2025
Q2
$7.31M Hold
301,435
1.81% 10
2025
Q1
$7.64M Buy
301,435
+5,801
+2% +$152K 1.86% 11
2024
Q4
$7.84M Buy
295,634
+3,457
+1% +$93.8K 2.02% 12
2024
Q3
$8.46M Buy
292,177
+340
+0.1% +$9.92K 2.12% 13
2024
Q2
$8.17M Buy
291,837
+25,430
+10% +$700K 2.05% 13
2024
Q1
$7.39M Buy
266,407
+4,832
+2% +$134K 1.67% 12
2023
Q4
$7.53M Buy
261,575
+124,134
+90% +$3.75M 1.86% 11
2023
Q3
$4.56M Buy
137,441
+27,559
+25% +$975K 1.21% 14
2023
Q2
$4.03M Buy
109,882
+78,210
+247% +$3.04M 0.93% 15
2023
Q1
$1.29M Hold
31,672
0.3% 47
2022
Q4
$1.62M Hold
31,672
0.37% 53
2022
Q3
$1.39M Hold
31,672
0.28% 82
2022
Q2
$1.66M Hold
31,672
0.36% 52
2022
Q1
$1.64M Hold
31,672
0.26% 97
2021
Q4
$1.87M Sell
31,672
-3,433
-10% -$170K 0.3% 81
2021
Q3
$1.51M Hold
35,105
0.25% 92
2021
Q2
$1.38M Sell
35,105
-22,527
-39% -$876K 0.2% 115
2021
Q1
$2.09M Buy
57,632
+3,457
+6% +$123K 0.25% 98
2020
Q4
$2M Buy
+54,175
New +$1.99M 0.24% 106
2014
Q4
Sell
-4,790
Closed -$135K 53
2014
Q3
$135K Hold
4,790
0.03% 49
2014
Q2
$135K Sell
4,790
-3,689
-44% -$105K 0.03% 48
2014
Q1
$258K Hold
8,479
0.04% 49
2013
Q4
$247K Hold
8,479
0.04% 59
2013
Q3
$231K Hold
8,479
0.04% 58
2013
Q2
$226K Buy
+8,479
New +$234K 0.04% 59

Other funds holding PFE

Longfellow Investment Management's PFE Position: Q1 2026 in Review

Longfellow Investment Management held its Pfizer (PFE) position steady in Q1 2026 at 301,435 shares worth $8.46M. The position accounts for 1.76% of the portfolio, ranked #12.

Longfellow Investment Management first reported a position in PFE in Q2 2013 and has held it in 28 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Longfellow Investment Management held 301,435 shares of Pfizer worth $8.46M as of Q1 2026.
  • Longfellow Investment Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 1.76% of Longfellow Investment Management's portfolio in Q1 2026, its #12 holding.
  • Longfellow Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 28 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Longfellow Investment Management's 13F filing for Q1 2026, filed 12 May 2026.